SequelSEC

MANGOCEUTICALS, INC. MGRX

Services-Misc Health & Allied Services, NEC · CIK 0001938046 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$68.76K
Fiscal year ended 2026-06-30
Operating income
-$1.03M
Fiscal year ended 2026-06-30
Free cash flow
Unavailable
Fiscal year ended 2026-06-30

MANGOCEUTICALS, INC. (MGRX) reported revenue of $68.76K and net income of -$1.31M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from MANGOCEUTICALS, INC.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Misc Health & Allied Services, NEC.

Income

MANGOCEUTICALS, INC. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Revenue$68.76K$67.86K$94.36K$84.25K$168.11K$109.31K$105.25K$133.37K$163.16K$214.10K
Cost of revenueUnavailableUnavailable$8.51KUnavailableUnavailableUnavailable$21.33KUnavailableUnavailableUnavailable
Gross profitUnavailableUnavailable$47.48KUnavailableUnavailableUnavailable$80.10KUnavailableUnavailableUnavailable
Operating income-$1.03M-$3.13M-$367.74K-$7.54M-$5.27M-$4.58M-$1.68M-$1.76M-$2.17M-$2.37M
Net income-$1.31M-$3.40M-$2.77M-$7.62M-$5.42M-$4.84M-$1.95M-$2.00M-$2.39M-$2.37M
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 17.12Mshares 16.48MUnavailableshares 11.52Mshares 9.98Mshares 4.59MUnavailableshares 2.01Mshares 1.74Mshares 1.57M
Pretax income-$1.31M-$3.40M-$2.77M-$7.62M-$5.42M-$4.84M-$1.95M-$2.00M-$2.39M-$2.37M
Income tax expenseUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Diluted EPS$-0.09$-0.22Unavailable$-0.69$-0.57$-1.12Unavailable$-1.14$-1.37$-1.50
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$256.10K$1.05M$657.19K$311.38K$1.25M$1.54M$854.05K$523.86K$850.70K$771.96K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

MANGOCEUTICALS, INC. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Cash & equivalents$228.69K$174.56K$1.49M$481.28K$101.02K$76.50K$58.65K$73.91K$490.24K$15.30K
Total assets$14.17M$14.45M$16.09M$16.53M$20.84M$21.75M$15.37M$14.79M$15.24M$301.45K
Current assets$245.69K$212.47K$1.55M$598.22K$117.96K$176.65K$75.60K$104.07K$517.56K$89.81K
Total liabilities$1.65M$974.57K$890.57K$804.28K$1.60M$1.50M$1.43M$1.40M$1.41M$1.26M
Current liabilities$1.40M$737.61K$890.57K$804.28K$1.60M$1.50M$1.43M$1.39M$1.38M$1.21M
Total equity incl. NCI$12.52M$13.47M$15.20M$15.73M$19.24M$20.25M$13.95M$13.83M$13.83M-$958.47K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$13.21K$14.02K$14.45K
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Cash flow

MANGOCEUTICALS, INC. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Operating cash flow-$260.51K-$1.31M-$1.08M-$1.24M-$1.26M-$2.27M-$1.13M-$1.17M-$1.58M-$991.13K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable$0$0UnavailableUnavailable
Financing cash flowUnavailableUnavailable$2.08M$1.62M$1.28M$2.28M$1.12M$750.00K$1.99M$267.50K
Net change in cashUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Stock-based compensation$12.42K$1.09M-$33.47K$1.10M$50.98K$50.98K$50.98K$108.76K$50.98K$37.96K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailable$256$252$250$255$3.46K$0$6.22K

Derived

MANGOCEUTICALS, INC. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailableUnavailable50.3%UnavailableUnavailableUnavailable76.1%UnavailableUnavailableUnavailable
Operating margin-1502.5%-4606.8%-389.7%-8953.5%-3134.0%-4186.8%-1594.0%-1318.2%-1329.1%-1105.9%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenue18.1%1606.3%-35.5%1305.5%30.3%46.6%48.4%81.5%31.2%17.7%
Current ratio0.18x0.29x1.74x0.74x0.07x0.12x0.05x0.07x0.38x0.07x
Revenue YoY growth-59.1%-37.9%-10.3%-36.8%3.0%-48.9%-56.9%-45.6%15.5%112.6%
Net margin-1909.1%-5014.7%-2935.1%-9042.8%-3221.6%-4427.4%-1851.2%-1499.0%-1465.4%-1105.9%
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MGRX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-13View SEC filing
10-Q · Filed 2026-05-19View SEC filing
10-K · Filed 2026-04-01View SEC filing
10-Q/A · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-11-14View SEC filing
10-Q · Filed 2025-08-14View SEC filing

Companies in the same industry

AGL BRTX CCEL DVA MRAI PARK PFHO PGNY SHC VMD

Reconciliation checks needing review

11 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2026-06-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2026-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-09-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-06-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2025-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-09-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-06-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2024-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-09-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-06-30

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.

gross profit bridgeinconsistent2023-03-31

Withheld: cost revenue could not be reconciled with the rest of this filer’s statement.